Jerry Topolski

Jerry is a partner in the Litigation and Dispute Resolution Group at Goodmans. He maintains a broad corporate and commercial litigation practice with particular expertise in regulatory dispute resolution and litigation, intellectual property disputes and complex commercial matters.

Jerry regularly advises clients in the pharmaceutical and life sciences industries on regulatory and commercial issues related to regulated products, including pharmaceuticals, medical devices, cannabis and natural health products. His work includes advising on regulatory compliance, product licensing, labelling and advertising, market access, and enforcement strategy. He frequently assists clients in navigating interactions with Health Canada and other federal, provincial and municipal regulators.

Drawing on extensive experience in both litigation and regulatory advisory work, Jerry supports clients across all stages of growth—from emerging market entrants to established multinational players. He provides practical legal and strategic advice to clients entering or operating in the Canadian market, including on regulatory risk, compliance obligations, litigation exposure, and enforcement trends.

In addition to his regulatory and IP-focused work, Jerry advises on shareholder disputes, white collar investigations, bankruptcy proceedings, employment litigation, and construction-related claims. He brings particular strength in managing multi-jurisdictional disputes and aligning litigation and regulatory strategies.

Jerry has appeared before all levels of the Federal, Ontario and Quebec Courts and is experienced in coordinating parallel proceedings across jurisdictions.

He is recognized as a leading lawyer in The Canadian Legal Lexpert Directory for litigation – intellectual property and Best Lawyers in Canada for intellectual property and corporate and commercial litigation. He is also featured in the Lexpert Special Edition: Technology and the Lexpert Special Edition: Health Sciences. 

Jerry and Justice Allyson Whyte Nowak of the Federal Court of Canada are authors of Best Practices In Litigating Complex IP Litigation, a guide to ethical considerations in pharmaceutical practice.